Skip to content

Hemodynamic profiles of remimazolam combined with low-dose- S-ketamine for induction of anesthesia in shock patients : A randomized controlled trial

Hemodynamic profiles of remimazolam combined with low-dose- S-ketamine for induction of anesthesia in shock patients : A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066745
Enrollment
Unknown
Registered
2022-12-15
Start date
2022-12-30
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shock patients

Interventions

etomidate:etomidate 0.1mg/(kg*min)

Sponsors

Fisrt Hospital of Putian, Putian,Fujian
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Age over 18 years; 2) American Society of Anesthesiologists (ASA) classification II–III; 3) Shock patients:0.7<shock index<2.0;4) Emergency operation under general anesthesia.

Exclusion criteria

Exclusion criteria: 1)Severe shock or dying person with shock index = 2.0;2)Cardiac insufficiency (EF<40% or NYHA classification III to IV); 3) arrhythmias (such as second- or third-degree atrioventricular block or atrial fibrillation); 4) unstable ischemic heart disease; 5) valvular heart disease with significant hemodynamic fluctuations;6) received pacemaker implantation; 7) body mass index more than 30; 8) predicted or history of difficulty airway; 9) pyloric or high intestinal obstruction; 10) allergic or contraindications to study drugs; 11) history of drug or alcohol abuse; 12) any other conditions that precluded participation judged by the primary investigator.

Design outcomes

Primary

MeasureTime frame
Area under the baseline MAP over the first 15 min after induction;the baseline CI over the first 15 min after induction;the baseline SVV over the first 15 min after induction;

Secondary

MeasureTime frame
the baseline HR over the first 15 min after induction;Dosage of vasoactive drugs over the first 15 min after induction;Time to loss of consciousness;BIS values at the time of loss of consciousness;

Countries

China

Contacts

Public ContactShurong Li

Fisrt Hospital of Putian, Putian,Fujian

lsrywpt@163.com13959579688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026